Sign In
Buy CNS
$70.20
-1.00 (-1.40%)
At Close: Jun 03, 2026
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
04:50pm, Friday, 27'th Sep 2024
NEW YORK , Sept. 27, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
04:49pm, Friday, 27'th Sep 2024
NEW YORK , Sept. 27, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the s
Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)
04:49pm, Friday, 27'th Sep 2024
NEW YORK , Sept. 27, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the di
Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)
04:46pm, Friday, 27'th Sep 2024
NEW YORK , Sept. 27, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of
Corero Network Security To Hold Investor Calls Following Strong H1 2024 Results
07:00am, Tuesday, 24'th Sep 2024
LONDON , Sept. 24, 2024 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQB: DDOSF), the distributed denial of service (DDoS) protection specialists, will hold investor calls this week to discus
CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
09:00am, Monday, 23'rd Sep 2024
Webcast presentation on Wednesday, September 25th at 1:55 PM CEST HOUSTON, TX / ACCESSWIRE / September 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical
CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement
09:00am, Thursday, 12'th Sep 2024
HOUSTON, TX / ACCESSWIRE / September 12, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for pr
Cohen & Steers Joins SUBSCRIBE Alternative Investment Platform to Expand Private Real Estate Access for Private Wealth Channel
06:00am, Thursday, 12'th Sep 2024
NEW YORK , Sept. 12, 2024 /PRNewswire/ -- SUBSCRIBE, a leading operating system for alternative investments serving institutional investors, wealth management firms, and fund managers, announced today
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows For August 2024
04:20pm, Tuesday, 10'th Sep 2024
NEW YORK , Sept. 10, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $88.1 billion as of August 31, 2024, an increase of $3.5 billion from a
CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
09:05am, Wednesday, 04'th Sep 2024
HOUSTON, TX / ACCESSWIRE / September 4, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for pri
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
05:14pm, Wednesday, 28'th Aug 2024
NEW YORK , Aug. 28, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources o
Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)
05:08pm, Wednesday, 28'th Aug 2024
NEW YORK , Aug. 28, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of th
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
05:05pm, Wednesday, 28'th Aug 2024
NEW YORK , Aug. 28, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the so
Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)
04:51pm, Wednesday, 28'th Aug 2024
NEW YORK , Aug. 28, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the di
CNS Pharmaceuticals to Participate in at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
09:10am, Tuesday, 27'th Aug 2024
Live webcast on Wednesday, August 28th at 3:20 PM ET HOUSTON, TX / ACCESSWIRE / August 27, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company speciali
